A review of the last decade: pancreatic cancer and type 2 diabetes

被引：1

作者：

Wu, Jiaqi ^{[1
,2
]}

Tang, Liang ^{[3
]}

Zheng, Feng ^{[4
]}

Chen, Xun ^{[5
,6
]}

Li, Lei ^{[7
]}

机构：

[1] Southern Med Univ, Nanfang Hosp, Guangzhou, Peoples R China

[2] Southern Med Univ, Sch Nursing, Guangzhou, Peoples R China

[3] Zhuzhou Cent Hosp, Dept Gen Med, Zhuzhou, Peoples R China

[4] Univ Otago, Dept Anat, Dunedin, New Zealand

[5] Zhuzhou Cent Hosp, Dept Trauma Ctr, 116 Changjiang Rd, Zhuzhou 412000, Peoples R China

[6] Zhuzhou Cent Hosp, Dept Hepatobiliary Surg, 116 Changjiang Rd, Zhuzhou 412000, Peoples R China

[7] Univ Otago, Dept Pathol, Dunedin 9016, New Zealand

来源：

ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY | 2024年 / 130卷 / 06期

关键词：

Pancreatic cancer; type; 2; diabetes; relationship; 10; years; drugs; SIGNALING PATHWAY; SGLT2; INHIBITORS; CLINICAL-USE; P38; MAPK; PROMOTES; CELLS; PROGRESSION; MECHANISMS; OBESITY; RAGE;

D O I：

10.1080/13813455.2023.2252204

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Pancreatic cancer (PC) is a prevalent gastrointestinal tumour known for its high degree of malignancy, resulting in a mere 10% five-year survival rate for most patients. Over the past decade, a growing body of research has shed light on the intricate bidirectional association between PC and Type 2 diabetes (T2DM). The collection of PC- and T2DM-related articles is derived from two comprehensive databases, namely WOS (Web of Science Core Collection) and CNKI (China National Knowledge Infrastructure). This article discusses the last 10 years of research trends in PC and T2DM and explores their potential regulatory relationship as well as related medications.

引用

页码：660 / 668

页数：9

共 50 条

[1] DYSLIPIDEMIA CONTROL IN TYPE 2 DIABETES: EXPERIENCE OF A PORTUGUESE CENTRE IN THE LAST DECADE
Sequeira Duarte, J.
Tavares Bello, C.
Fonseca, R.
Ferreira, R.
Oliveira, M.
Saraiva, C.
Gouveia, C.
Santos, F.
Azinheira, J.
Vasconcelos, C.
ATHEROSCLEROSIS, 2016, 252 : E135 - E135
[2] The Role of Type 2 Diabetes in Pancreatic Cancer
George, Sheeba
Jean-Baptiste, Wilford
Ali, Amina Yusuf
Inyang, Bithaiah
Koshy, Feeba Sam
George, Kitty
Poudel, Prakar
Chalasani, Roopa
Goonathilake, Mastiyage R.
Waqar, Sara
Mohammed, Lubna
CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (06)
[3] Type 2 Diabetes Mellitus and Pancreatic Cancer
McAuliffe, John C.
Christein, John D.
SURGICAL CLINICS OF NORTH AMERICA, 2013, 93 (03) : 619 - +
[4] Revision of type I diabetes in childhood during the last decade
Freijo, Concepcion C.
Guerra, Jose Lorenzo J. L.
Luzuriaga, Cristina C.
HORMONE RESEARCH, 2009, 72 : 160 - 160
[5] Cost of treatment and metabolic profile of patients with type 2 diabetes during the last decade
Papaoikonomou, S.
Liatis, S.
Dimopoulos, S.
Thomakos, P.
Tombrou, I.
Katsilambros, N.
DIABETOLOGIA, 2007, 50 : S428 - S428
[6] Diabetes Type 2 and Pancreatic Cancer: A History Unfolding
De Souza, Andre
Irfan, Khawaja
Masud, Faisal
Saif, Muhammad Wasif
JOURNAL OF THE PANCREAS, 2016, 17 (02): : 144 - 148
[7] Is Type 2 Diabetes a Risk Factor for Pancreatic Cancer?
Pezzilli, Raffaele
Casadei, Riccardo
Morselli-Labate, Antonio Maria
JOURNAL OF THE PANCREAS, 2009, 10 (06): : 705 - 706
[8] Effectiveness of Interventional Studies on Type 2 Diabetes: A Decade Systematic Review
Dorosteh, Ameneh Pooresmaeil
Ghaffari, Mohtasham
Rakhshanderou, Sakineh
HEALTH SCOPE, 2022, 11 (02):
[9] Pancreatic cancer in the general population: Improvements in survival over the last decade
Taylor S. Riall
William H. Nealon
James S. Goodwin
Dong Zhang
Yong-Fang Kuo
Courtney M. Townsend
Jean L. Freeman
Journal of Gastrointestinal Surgery, 2006, 10 : 1212 - 1224
[10] Pancreatic cancer in the general population: Improvements in survival over the last decade
Riall, Taylor S.
Nealon, William H.
Goodwill, James S.
Zhang, Dong
Kuo, Yong-Fang
Townsend, Courtney M., Jr.
Freeman, Jean L.
JOURNAL OF GASTROINTESTINAL SURGERY, 2006, 10 (09) : 1212 - 1223

← 1 2 3 4 5 →